The Union Ministry of Health and Family Welfare has introduced significant changes to India's drug regulatory framework by making a doctor's prescription mandatory for the purchase of cough syrups and other syrup-based medicines. The decision is part of the Drugs (Fifth Amendment) Rules, 2026, which were notified by the central government and incorporated into the Drugs Rules, 1945.
Under the revised regulations, syrup formulations have been removed from Schedule K, a category that previously allowed certain medicines to be sold with regulatory exemptions. With the removal of the term "syrups" from the schedule, these medicines will now be subject to stricter controls and can only be purchased with a valid prescription issued by a registered medical practitioner.
The government's decision is aimed at strengthening patient safety and ensuring responsible use of medicines. Health authorities have expressed concerns over the misuse, overuse and unsupervised consumption of cough syrups and other liquid formulations. By introducing prescription requirements, regulators hope to ensure that patients receive appropriate medical advice before using such medicines.
The amendment follows a regulatory review process that began with a draft proposal issued by the Health Ministry in late 2025. The proposal sought public feedback on removing syrup formulations from Schedule K. After considering stakeholder responses and recommendations from regulatory bodies, the government finalized the amendment in 2026.
Officials have stated that the move is intended to improve oversight of medicine distribution and reduce risks associated with inappropriate use of syrup-based drugs. Regulatory experts note that liquid medicines often require careful dosage management, particularly for children and elderly patients. Restricting sales to prescription-based purchases is expected to encourage safer consumption practices.
The revised rules will affect pharmacies and medical stores across the country. Retailers will now be required to verify prescriptions before dispensing cough syrups and other syrup formulations covered under the amendment. Consumers who were previously able to purchase such medicines over the counter will need to consult a healthcare professional before obtaining them.
Healthcare experts believe the regulation could help reduce self-medication, a practice that remains common in many parts of the country. They argue that professional medical guidance can improve treatment outcomes and lower the risks associated with incorrect medicine use. At the same time, pharmacists and healthcare providers may need to educate consumers about the new requirements to ensure a smooth transition.
The amendment represents one of the most notable changes to medicine sales regulations in recent years. It reflects the government's broader efforts to strengthen drug safety standards, improve regulatory oversight and promote responsible healthcare practices across India. As the new rules come into effect, both consumers and retailers will need to adapt to the updated prescription requirements for syrup-based medicines